SSAT Home SSAT Annual Meeting

Annual Meeting Home
Past & Future Meetings
Photo Gallery
 

2012 Annual Meeting Posters: Monday, May 21, 2012

53rd Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
May 18 - 22, 2012
San Diego Convention Center - San Diego, California
during Digestive Disease Week®


Program (Subject to Change)
Last Updated 02/13/12

All rooms at San Diego Convention Center unless otherwise indicated.



<< Sunday | Posters Home | Tuesday>>

SSAT POSTER SESSIONS

The SSAT Poster Sessions will be held in Halls C-G of the San Diego Convention Center, from 8:00 AM – 5:00 PM. Authors will be at their posters to answer questions from 12:00 PM – 2:00 PM.

Designated presenting authors listed. View a complete author string with abstract by clicking on the poster title.

indicates a Poster of Distinction.

Monday, May 21, 2012

Basic: Biliary
P90 Persistent Symptoms Following Cholecystectomy Is Unacceptably High and in Need of Further Evaluation
Rami Radwan, Minimal Access Surgery, Royal Gwent Hospital, Barry United Kingdom

Basic: Colon-Rectal
P91 Human Growth Hormone (hGH) Abolishes the Negative Effects of Everolimus on Intestinal Anastomotic Healing
Markus Alexander Küper, Department for General, Visceral and Transplant Surgery, University of Tübingen, Tübingen Germany
P92 Intestinal Permeability for Macromolecules Following Mechanical Ileus in Mice
Martin E. Kreis, Surgery, University of Munich, Munich Germany
P93 Intra-Abdominal Adipose Tissue as a Major Source of IL-6 During Acute Experimental Colitis
W. Conan Mustain, Markey Cancer Center, Department of Surgery, University of Kentucky, University of Kentucky, Lexington, KY

Basic: Esophageal
P95 EGFR in Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Esophageal Adenocarcinoma
Guilherme Pretto, Programa de Pós-Graduação em Cirurgia, Digestive Surgery, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul Brazil

Basic: Pancreas
P96 Effects of Intravenous Administration of Pentoxifylline in Pancreatic Ischemia/Reperfusion Injury
Ana Maria M. Coelho, Gastroenterology, University of Sao Paulo, Sao Paulo Brazil
P97 The Expression of Putative Pancreatic Stem Cell Marker DCAMKL-1 Is Elevated in Early Stage Pancreatic Adenocarcinoma Patients
Jeremy Jon Johnson, Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK
P98 DNA Methylation as a Biomarker System for Pancreatic Adenocarcinoma
Qi Huang, Biology, Indiana University , Bloomington, IN

Basic: Small Bowel
P100 Changes in Neurotransmission via α1- and α2-Receptors During Postoperative Ileus in Rat
Bernhard Stoklas, Department of Surgery, Ludwig-Maximilians-University Munich, Munich Germany

Basic: Stomach
P101 Intratumoral Epcam Expression in Gastric Cancer: A Potential Prognostic Marker and Therapeutic Target
Daniel Vallbohmer, Department of General, Visceral and Paediatric Surgery, University of Dusseldorf, Dussledorf Germany

Clinical: Biliary
P102 Extended Left Hepatic Trisectionectomy as a Feasible Surgical Procedure for Advanced Perihilar Cholangiocarcinoma
Minoru Esaki, Hepato-biliary pancreatic surgery, National Cancer Center Hospital, Tokyo Japan
P103 Audit of the Use of Critical View of Safety and Infundibular Cystic Technique in Cystic Duct Identification in Laparoscopic Cholecystectomy
Anokha Oomman, Gwent Institute of Minimal Access Surgery, Withybush General Hospital, Royal Gwent Hospital, Haverfordwest United Kingdom
P104 Self-Expandable Metallic Stents Do Not Impact on the Frequency of Complications Related to Preoperative Biliary Drainage or Subsequent Pancreatoduodenectomy
Wesley D. Leung, Gastroenterology, Indiana University , Indianapolis, IN
P105 The Influence of Analgesia, Antiemetics and Operative Factors on Admission Following Cholecystectomy: A Retrospective Review
Mark Bignell, General Surgery, Norfolk and Norwich university Hospital, Norwich United Kingdom
P106 Perioperative Outcomes of Patients Undergoing Laparoscopic Cholecystectomy: The Critical Impact of Age and Operative Status
Imran Hassan, SIU School of Medicine, Springfield, IL
P107 Is HIDA Scan Necessary for Sonographically Suspicious Cholecystitis?
Irina Bernescu, Surgery, Robert Wood Johnson UMDNJ, New Brunswick, NJ
P108 Costs Associated with Delayed Cholecystectomy After a Biliary Migration
Charles Ménard, Gastro-enterology, Sherbrooke, Sherbrooke, QC Canada

Clinical: Colon-Rectal
P109 Colostomy vs. Ileostomy: An ACS-NSQIP Evaluation of Complications from Diverting Stoma Reversal
Dhruvil R. Shah, Surgery, University of California Davis, Sacramento, CA
P111 Impact of Operative Duration on Postoperative Pulmonary Complications Among Patients Undergoing Complex Gastrointestinal Procedures
Rachel Medbery Owen, Surgery, Emory University, Atlanta, GA
P112 Microlaparoscopic Colectomy: Initial Experience
Christopher Foglia, Surgery, Danbury Hospital, Danbury, CT
P113 Longer LOS Yet Similar Return of BM for Hand-Assisted (vs. Laparoscopic) Colorectal Resection Patients Who Had a Higher BMI and Risk Profile
Samer Naffouje, Department of Surgery, St. Luke's Roosevelt Hospital Center, New York, NY
P114 Predictors of Successful Pelvic Reoperations in Colorectal Surgery: A Multivariate Analysis
Emanuela Silva, Colorectal Surgery, Cleveland Clinic Florida, Weston, FL
P115 Ethnicity Defines the Risk of Crohn’s Disease of the Ileoanal Pouch
Saurabh Mukewar, Cleveland Clinic Foundation, Ohio, Cleveland, OH
P116 Intestinal Surgery for Crohn’s Disease: Role of Preoperative Therapy in Postoperative Outcome
Marco Scarpa, Oncological Surgery Unit, Venetian Oncology Institute (IOV-IRCCS), Padova Italy
P117 Factors Associated with Long-Term Quality of Life (QL) After Ileocolic Resection (ICR) for Crohn’s Disease
Felipe Bellolio, Surgery, Zane Cohen Centre for Digestive Diseases, Samuel Lunenfeld Research Institute, University of Toronto, Mount Sinai Hospital, Toronto, ON Canada
P118 Is Laparoscopic Resection for Recurrent Disease Beneficial in Patients with Previous Intestinal Resection for Crohn’s Disease Through Midline Laparotomy? A Case-Matched Study
Erman Aytac, Colorectal Surgery, Cleveland Clinic Foundation Digestive Disease Institute, Cleveland, OH
P119 Nervosa Anorexia Leads to Defaecatory Disorders Compared to General Population
Luana Franceschilli, surgery, university of rome tor vergata, Rome Italy
P120 Role of Metastatic Lymph Node Ratio as a Prognostic Index in Colorectal Cancer Surgery
Stefano D' Ugo, surgery, university of rome tor vergata, Roma Italy
P122 Does Laparoscopic Colectomy Have Reduced Post-Operative Morbidity and Mortality in Octogenarians Compared to Open?
Muhammad Asad Khan, Surgery, Staten Island University Hospital, Staten Island, NY
P123 Does the Laparoscopic Approach to Colectomy Lessen the Post-Operative Complications in Octogenarians?
Muhammad Asad Khan, Surgery, Staten Island University Hospital, Staten Island, NY
P124 Endoscopic Resection of Rectal NETs: Establishing Guidelines for Oncologic Endpoints
Thomas Curran, Surgery , Beth Israel Deaconess Medical Center, Boston, MA

Clinical: Esophageal
P125 The Clinical and Economic Cost of Delirium Following Surgical Resection for Esophageal Malignancy
Sheraz Markar, Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA
P126 The Incidence of Hiatal Hernia After Minimally Invasive Esophagectomy
Nathan Windham Bronson, Department of General Surgery, Oregon Health and Science University, Portland, OR
P127 The Utility of Esophageal Stents as an Adjunct in the Perioperative Management of Cancer of the Esophagus
Nicolas Zea, Department of Surgery, Ochsner Health Systems, New Orleans, LA
P128 The Impact of Impedance (MII) Testing on Patient Selection for Anti-Reflux Surgery in the Setting of a Normal 24-Hour pH Test
Ashwin Antony Kurian, Providence Portland , Portland, OR
P129 Automatic Cancer Staging for Esophageal Pathological Reports by Text Mining and Data Mining: Comparison Between AJCC 6th and 7th Editions
Yung-Han Sun, Department of Surgery, Department of Information Management, Taipei-Veterans General Hospital, Chang Gung University, Taipei Taiwan
P130 pH-Symptom Indices Do Not Predict Symptom Improvement After Antireflux Surgery
Stefan Niebisch, Department of Surgery, University of Rochester Medical Center, Rochester, NY
P131 Operative Outcomes of Colonic Interposition in the Treatment of Esophageal Cancer: A Three Decades Experience
Daniel K.H. Tong, Surgery, The University of Hong Kong, Hong Kong Hong Kong
P132 Short-Term Outcome of Antireflux Surgery on Patients with Chronic Cough and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal Impedance
Toshitaka Hoppo, Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
P133 PET-CT for Response Assessment of Neoadjuvant Chemoradiation in Locally Advanced Squamous Cell Carcinoma Esophagus: Initial Experience from Tertiary Referral Center in North India
Saurabh Kalia, PGIMER, Chandigarh, India, Chandigarh India
P134 Routine Barium Esophagram Has Minimal Impact on the Post-Operative Management of Patients Undergoing Esophagectomy for Esophageal Cancer
Maxime Noreau-Nguyen, Surgery, McGill University, St Lambert, QC Canada
P135 Effective Endoscopic Treatment of Gastroesophageal Reflux Disease Using a New Endoscopic Stapling System Results of a Prospective Controlled Multicenter Tria
Aviel Roy-Shapira, Surgery A, Critical Care Medicine, Soroka Univesity Hospital, Soroka University Hospital, Beer Sheva Israel
P136 Resolution of Anemia Following Repair of Giant Paraesophageal Hernias
Michael Hermansson, Surgery, Keck medical center of USC, University of Southern California, Los Angeles, CA
P137 Annual CT Scans Do Not Improve Survival Following Oesphagectomy for Cancer: A Follow Up Study of 126 Patients
Stefan Samad Antonowicz, Upper GI Surgery, MEHT, Chelmsford, Essex United Kingdom
P138 Influence of Postoperative Morbidity on Longterm Cancer Survival After Esophagogastric Surgery
Steve Satheesan, Surgery, University Hospitals of Leicester NHS Trust, Leicester United Kingdom
P139 Symptomatic and Radiographic Evaluation of Hiatal Hernia Recurrence Following Laparoscopic Paraesophageal Hernia Repair with Polyester Composite Mesh Reinforcement
Mark Wendling, Division of General and Gastrointestinal Surgery, The Ohio State University Medical Center, Columbus, OH

Clinical: Hepatic
P140 Safety of a Multimodal Enhanced Recovery Pathway in Liver Resection Surgery
Clancy J. Clark, Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN
P141 Prediction of Survival After Surgery in Patients with Liver Cirrhosis
Hannes Philipp Neeff, Dept. of Surgery, University of Freiburg, Freiburg Germany
P142 Patterns and Prognostic Significance of Lymph-Node Dissection for Surgical Treatment of Peri-Hilar and Intrahepatic Cholangiocarcinoma
Andrea Ruzzenente, Chirurgia Generale A , Policlinico GB Rossi, Verona Italy
P143 Serum Markers for Predicting Surgical Outcomes in Patients with Cirrhosis
Malika Garg, Surgery, The Mount Sinai School of Medicine, New York, NY

Clinical: Pancreas
P145 Quality of Life in Patients After Total Pancreatectomy Is Comparable to Quality of Life in Patients After a Partial Pancreatic Resection.
Irene Epelboym, Surgery, New York Presbyterian, Columbia University, New York, NY
P146 Defining Quality for Distal Pancreatectomy: Does the Laparoscopic Approach Protect Patients from Poor Quality Outcomes?
Marshall Baker, Surgery, Surgery, NorthShore University Health System, University of Chicago, Pritzker School of Medicine, Evanston, IL
P147 Clinical Pathway for Pancreaticoduodenectomy Improves Short Term Outcomes at a Rural Tertiary Care Center
Halle Beitollahi, General Surgery, Geisinger Medical Center, Danville , PA
P148 Postoperative Systemic Inflammatory Response Syndrome Is a Predictor of Major Complication After Pancreatoduodenectomy
Naru Kondo, Mayo Clinic, Rochester, MN
P149 Bioabsorbable Staple Line Reinforcement Reduces Risk of Fistula Following Pancreatic Resection
Eric Hans Jensen, Surgery, University of Minnesota Medical Center, Minneapolis, MN
P150 Indications for Total Pancreatectomy and Islet Auto-Infusion Beyond Chronic Pancreatitis with Intractable Pain
Marlon F. Levy, Division of Gastroenterology, , Baylor All Saints Medical Center, Baylor Regional Transplant Institute, Ft. Worth, TX
P151 Does Pancreatic Stump Closure Method Influence Fistula Rate After Distal Pancreatectomy
Eugene P. Ceppa, Surgery, Indiana University Medical Center, Indianapolis, IN
P152 Reduction in Delayed Gastric Emptying Following Non-Pylorus Preserving Pancreaticoduodenectomy by Addition of Braun Enteroenterostomy
Mehrdad Nikfarjam, Surgery, University of Melbourne, Melbourne, VIC Australia
P153 Duct-to-Mucosa Pancreaticogastrostomy Reduces Postoperative Pancreatic Stump Leak Rates After Distal Pancreatectomy
Yasushi Hashimoto, Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University , Hiroshima, Hiroshima Japan
P154 Risk Factors, Hospital Cost, and Complications Associated with Transfusion in Elective Pancreatectomy
Raphael C. Sun, Surgery, Univ of Iowa, Iowa City, IA
P155 Laparoscopic Distal Pancreatectomy for Benign and Malignant Lesions: A Nationwide Analysis of Patient Outcomes
Hop S. Tran Cao, Department of Surgery, University of California, San Diego, San Diego, CA
P156 Contemporary Treatment and Outcomes of Periampullary Adenocarcinomas at a Single Institution
Vei Shaun Siow, Thomas Jefferson University Hospital, Philadelphia, PA
P158 Predictive Factors of Pancreatic Fistula and Postoperative Complications After Pancreatic Resections in Two High Volume Centers: Comparison Between Posterior Invagination and Duct-to-Mucosa Pancreaticogastrostomy
Filippo Scopelliti, Department of Surgery, Verona University, Verona Italy
P159 Pancreaticoduodenectomy at High Volume Centers: Surgeon Volume Goes Beyond the Leapfrog Criteria
Abhishek Mathur, Surgery, University of South Florida, Tampa, FL

Clinical: Small Bowel
P160 Double Balloon Enteroscopy in Patients with Surgically Altered Bowel Anatomy: Analysis of Large Prospectively Collected Database
Mihir K. Patel, Gastroenterology, Mayo Clinic, Jacksonville, FL
P161 Fifteen Cases of Superior Mesenteric Artery Syndrome: Diagnosis and Surgical Strategies
Imerio Angriman, Surgical & Gastroenterologic Science, University of Padova, University of Padova, Padova Italy
P162 Impact of Abdominal Insufflation for Laparoscopy on Intracranial Pressure
Tovy Haber Kamine, Surgery, BIDMC, Cambridge, MA
P163 Effects of Preoperative Enteral Glutamine and Arginine in Patients Submitted to Surgical Treatment of Enterocutaneous Fistulas
Enrique Luque-de-León, Gastrocirugía, UMAE Hospital Especialidades Centro Médico Nacional SXXI, Mexico, Distrito Federal Mexico

Clinical: Stomach
P164 Revisional Bariatric Surgery for Weight Regain and Complications
Hideharu Shimizu, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH
P165 Correlation Between Gastric Emptying Time and Weight Loss After Silastic Ring Roux-en-y Gastric Bypass
Fernando Herbella, Digestive Surgery, unifesp, Sao Paulo Brazil
P166 Change in National Trends Adversely Impact Survival in Stage IV Gastric Cancer
Anna Mary Leung, Department of Surgery, John Wayne Cancer Institute, Santa Monica, CA
P167 Urinary Evaluation After RYGBP: A Lithogenic Profile with Early Postoperative Increase in the Incidence of Urolithiasis
Fernando Herbella, Surgery, Paulista School of Medicine, Universty of Londrina, São Paulo, Sào Paulo Brazil
P168 Gastric Electrical Stimulation for Symptom Control of Patients with Diabetic, Idiopathic, and Post Surgical Gastroparesis
Samira Hasan, St. Vincent Hospital, Indianapolis, IN
P169 GLP-1 Analogues Do Not Improve Remission of Diabetes After Gastric Bypass
Andrew A. Taitano, General Surgery, Albany Medical Center, Albany, NY
P170 Newly-Devised Method for Totally Laparoscopic Total Gastrectomy (TLTG), Application Easiness and Cost Effectiveness: The Experience of Over 140 Cases in Single-Institution
Hitoshi Satodate, Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama Japan
P171 Preoperative Chemotherapy in High Risk Gastric Cancer: No Guarantee of Downstaging But Remains Our Best Magic Bullet
Veeraiah Siripurapu, Surgery, Methodist Dallas Medical Center, Dallas, TX
P172 Foregut Surgery in the Modern Era: A National Survey
Zeling Chau, Surgical Outcomes Analysis & Research, University of Massachusetts Medical School, Worcester, MA
P173 What Motivates Weight Loss Surgery Patients?
Nayna Amratlal Lodhia, Surgery, Stanford University, Palo Alto, CA

Translational Science: Colon-Rectal
P174 Thromboelastography Delineates Hypercoagulation in an Immunocompentent Murine Model of Metastatic Colon Cancer
Karen K. Lo, Surgery, Surgery, University of Colorado, Denver, Denver Health, Aurora, CO
P175 Reinforcing the High Risk Intestinal Anastomosis: Experimental Pilot Study
Jana Dziaková, Servicio de Cirugia I, , Hospital Clinico San Carlos, Universidad Complutense, Madrid Spain

Translational Science: Esophageal
P176 Impact of Blood Biomarker of Neoadjuvant Treated Patients with Esophageal Carcinoma
Peter P. Grimminger, Department of General-, Visceral- and Tumor surgery , University Clinic Cologne, Cologne Germany
P177 Training for Per-Oral Endoscopic Myotomy (POEM): Cadavers or Swine?
Dana Alexa Telem, Surgery, Massachusetts General Hospital, Boston, MA

Translational Science: Hepatic
P178 Triptolide Demonstrates Novel Chemotherapeutic Potential as Single-Agent or Combination Therapy with Sorafenib for Treatment of Hepatocellular Carcinoma
Tara C.K. Krosch, Department of Surgery, University of Minnesota, Minneapolis, MN

Translational Science: Stomach
P179 SNP Array 6.0 Analysis in Advanced Gastric Cancer Patients Treated with 5-FU and Platinum or Irinotecan Based Chemoradiation
Peter P. Grimminger, Department of General-, Visceral- and Tumor surgery , University Clinic Cologne, Cologne Germany



© 2024 Society for Surgery of the Alimentary Tract. All Rights Reserved. Read the Privacy Policy.